Jack Anders - 07 Jan 2026 Form 4 Insider Report for Revolution Medicines, Inc. (RVMD)

Signature
/s/ Jack Anders
Issuer symbol
RVMD
Transactions as of
07 Jan 2026
Net transactions value
-$555,500
Form type
4
Filing time
09 Jan 2026, 16:20:21 UTC
Previous filing
18 Dec 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Anders Jack Chief Financial Officer C/O REVOLUTION MEDICINES, INC., 700 SAGINAW DRIVE, REDWOOD CITY /s/ Jack Anders 09 Jan 2026 0001800668

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVMD Common Stock Options Exercise $424,500 +10,000 +9.3% $42.45 118,065 07 Jan 2026 Direct F1, F2
transaction RVMD Common Stock Sale $980,000 -10,000 -8.5% $98.00 108,065 07 Jan 2026 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVMD Stock Option (Right to Buy) Options Exercise $0 -10,000 -39% $0.000000 15,900 07 Jan 2026 Common Stock 10,000 $42.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 16, 2024.
F2 Includes 42,338 restricted stock units.